Why the study?
Is the I/D polymorphism of the angiotensin-converting enzyme gene associated with an increased risk of hypertension in a Nigerian population?
Is the I/D polymorphism of the angiotensin-converting enzyme gene associated with an increased risk of hypertension in a Nigerian population?
The ACE gene I/D polymorphism showed a trend toward increased hypertension risk in a South-South Nigerian population, which the authors concluded as a risk factor despite the confidence interval crossing 1.
Trend toward higher hypertension risk is inconclusive; leaves open clinical relevance of ACE I/D polymorphism in this population.
BACKGROUND: Hypertension is a public health challenge due to its high prevalence, and is a major risk factor for cardiovascular diseases. This study was designed to determine the frequency of the I/D polymorphism of the angiotensin-converting enzyme gene and its association with hypertension in a sample population of Calabar and Uyo, South-South Nigeria. MATERIALS AND METHODS: A population-based case control design consisting of total of 1224 participants, 612 each of patients and controls, were randomly recruited from hypertension clinics and the general population. The I/D polymorphism was investigated using polymerase chain reaction. Multiple regression and odds ratio (OR) was applied to test whether the ID genotypes were predictors of hypertension. RESULTS: The I/D genotype frequencies were 73(12%), 262(43%) and 277(45%); 74(12%), 303(50%) and 235(38%) for the II, ID, DD genotype in patient and control groups, respectively. A higher frequency of the ID genotype was observed in controls of which 208(61%) were females. By multiple regression analysis, age was a predictor for SBP in patients, r = 0.596, and DBP in controls, r = 0.555. Gender, Body mass index, I/D genotypes were not significant predictors for hypertension but the I/D polymorpism was associated with an increased risk for hypertension with an OR of 1.15 95%CI (0.924-1.456). CONCLUSION: The I/D polymorphism of the angiotensin-converting enzyme gene was a risk factor for hypertension in the sample population of Calabar and Uyo. This research will form baseline information for subsequent molecular studies in this population.
No takes yet. Share an insight, caveat, or question.
Kooffreh et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: